ClinicalTrials.gg
Sign In

Arteriovenous Malformations clinical trials

The registry lists 92 studies for Arteriovenous Malformations across more than 10 countries. 29 are recruiting or about to start. 49 of them are mainly about Arteriovenous Malformations (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Arteriovenous Fistula: 367 studies, 83 open.

Get an email when these change. Save the Arteriovenous Malformations studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
34
Recruiting
19
Status unknown
16
Not yet recruiting
9
Active, not recruiting
4
Withdrawn
4

Phase

Phase 2
12
Phase 1
8
Phase 4
4
Phase 3
1
Early Phase 1
1

Where

United States
32
China
15
France
15
Canada
8
Belgium
5
Italy
4

Who runs them

Beijing Tiantan Hospital (8) · Fondation Ophtalmologique Adolphe de Rothschild (4) · University of California, San Francisco (3) · Kaneka Corporation (2) · Hospices Civils de Lyon (2) · University of Arkansas (2) · University Health Network, Toronto (2) · Assiut University (2)

What is being tested here

Drugs under test in Arteriovenous Malformations studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Everolimus101
Sirolimus101
Alpelisib101
Mirdametinib101
Engasertib001
Cobimetinib001
Bevacizumab001
Minocycline001
Doxycycline001
Thalidomide001

Coming up

0phase 3 studies under way
9studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9

Who these studies take

Of the 19 Arteriovenous Malformations studies recruiting now, 13 (68%) set no upper age limit and 3 (16%) stop at 75 or younger. 8 (42%) take children under 18. 1 (5%) are for women only and 0 (0%) for men only; 2 (11%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
108 (42%)8 (42%)
1819 (100%)18 (95%)
3019 (100%)18 (95%)
4019 (100%)18 (95%)
5018 (95%)18 (95%)
6517 (89%)17 (89%)
7516 (84%)16 (84%)
8514 (74%)14 (74%)

Across all 92 studies, recruiting or not: 20% stop at 75 or younger and 11% at 65; 43% take children; 4% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Arteriovenous Malformations studies take

Of 15 interventional studies with no phase under Arteriovenous Malformations, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase33 mo17–77 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 → or search them.